Terms: = Germ cell tumor AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Diagnosis
48 results:
1. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
2. Biological Insight and Recent Advancement in the Treatment of Neuroblastoma.
Rivera Z; Escutia C; Madonna MB; Gupta KH
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239815
[TBL] [Abstract] [Full Text] [Related]
3. Co-occurrence of mutations in
Mellid S; Gil E; Letón R; Caleiras E; Honrado E; Richter S; Palacios N; Lahera M; Galofré JC; López-Fernández A; Calatayud M; Herrera-Martínez AD; Galvez MA; Matias-Guiu X; Balbín M; Korpershoek E; Lim ES; Maletta F; Lider S; Fliedner SMJ; Bechmann N; Eisenhofer G; Canu L; Rapizzi E; Bancos I; Robledo M; Cascón A
Front Endocrinol (Lausanne); 2022; 13():1070074. PubMed ID: 36760809
[TBL] [Abstract] [Full Text] [Related]
4. Acinar cell carcinoma with prkar1a and PTEN alterations and paraneoplastic panniculitis.
Yang Z; Zarate Rodriguez JG; Beck H; Byrnes K; Trikalinos NA; Hammill CW
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36549753
[TBL] [Abstract] [Full Text] [Related]
5. Immunotherapy for Pediatric Brain and Spine tumors: Current State and Future Directions.
Estevez-Ordonez D; Gary SE; Atchley TJ; Maleknia PD; George JA; Laskay NMB; Gross EG; Devulapalli RK; Johnston JM
Pediatr Neurosurg; 2023; 58(5):313-336. PubMed ID: 36549282
[TBL] [Abstract] [Full Text] [Related]
6. Immunotherapy approaches for the treatment of diffuse midline gliomas.
Bernstock JD; Hoffman SE; Kappel AD; Valdes PA; Essayed W; Klinger NV; Kang KD; Totsch SK; Olsen HE; Schlappi CW; Filipski K; Gessler FA; Baird L; Filbin MG; Hashizume R; Becher OJ; Friedman GK
Oncoimmunology; 2022; 11(1):2124058. PubMed ID: 36185807
[TBL] [Abstract] [Full Text] [Related]
7. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract] [Full Text] [Related]
8. Expression profiling of lncRNAs and mRNAs in placental site trophoblastic tumor (PSTT) by microarray.
Gan J; Chen Z; Feng X; Wei Z; Zhang S; Du Y; Xu C; Zhao H
Int J Med Sci; 2022; 19(1):1-12. PubMed ID: 34975294
[TBL] [Abstract] [Full Text] [Related]
9. Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments.
Soler DC; Kerstetter-Fogle A; McCormick TS; Sloan AE
J Neurooncol; 2022 Jan; 156(1):81-96. PubMed ID: 34825292
[TBL] [Abstract] [Full Text] [Related]
10. Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.
Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
Cancer Med; 2021 Aug; 10(15):5019-5030. PubMed ID: 34145792
[TBL] [Abstract] [Full Text] [Related]
11. Checkpoint inhibitors and radiotherapy in refractory malignant melanocytic schwannoma with carney complex: first evidence of efficacy.
Bajpai J; Kapoor A; Jalali R; Gounder MM
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34049890
[TBL] [Abstract] [Full Text] [Related]
12. GD2-specific car T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision.
Wang K; Chen Y; Ahn S; Zheng M; Landoni E; Dotti G; Savoldo B; Han Z
Nat Cancer; 2020 Oct; 1(10):990-997. PubMed ID: 33898999
[TBL] [Abstract] [Full Text] [Related]
13. Allogeneic Natural Killer and Cytomegalovirus (CMV)-pp65 Pulsed Dendritic cells Induced Complete Response Through 15 Months in a Patient with Recurrent Glioblastoma: A Case Study.
Gumrukcu S; Nguyen TX; White RL; Howell GT; Musikanth P
Am J Case Rep; 2021 Mar; 22():e931030. PubMed ID: 33788825
[TBL] [Abstract] [Full Text] [Related]
14. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic Pathology of tumors of Peripheral Nerve.
Belakhoua SM; Rodriguez FJ
Neurosurgery; 2021 Feb; 88(3):443-456. PubMed ID: 33588442
[TBL] [Abstract] [Full Text] [Related]
16. Cancer-associated retinopathy preceding the diagnosis of a pulmonary carcinoid tumour.
Merle G; Baglivo E; Younossian AB; Vijgen S; Karenovics W; Kherad O
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139354
[TBL] [Abstract] [Full Text] [Related]
17. Genomic and Clinicopathologic Characteristics of prkar1a-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
[TBL] [Abstract] [Full Text] [Related]
18. Melanotic Schwannoma of the Vulva: A Case Report and Review of the Literature.
Cohen JN; Yeh I; LeBoit PE
Am J Dermatopathol; 2020 Jan; 42(1):46-51. PubMed ID: 31268928
[TBL] [Abstract] [Full Text] [Related]
19. Distant metastasis due to heavily pigmented epithelioid melanoma with underlying BRAF V600E, NOTCH1, ERBB3, and PTEN mutations.
Motaparthi K; George EV; Guo R
J Cutan Pathol; 2019 Aug; 46(8):613-618. PubMed ID: 31025390
[TBL] [Abstract] [Full Text] [Related]
20. [Not Available].
Dourthe MÉ; Yakouben K; Chaillou D; Lesprit E; Dalle JH; Baruchel A
Bull Cancer; 2018 Dec; 105 Suppl 2():S147-S157. PubMed ID: 30686353
[TBL] [Abstract] [Full Text] [Related]
[Next]
